000			02093 a2200541 4500
005			20250517162322.0
264		0	_c20190319
008			201903s 0 0 eng d
022			_a1938-0666
024	7		_a10.1016/j.clbc.2017.05.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aSteger, Guenther G
245	0	0	_aSingle-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study. _h[electronic resource]
260			_bClinical breast cancer _c02 2018
300			_ae41-e47 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Phytogenic _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aBreast _xpathology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy-Induced Febrile Neutropenia _xepidemiology
650	0	4	_aDisease Progression
650	0	4	_aFatigue _xchemically induced
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aProgression-Free Survival
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aTreatment Outcome
650	0	4	_aVinorelbine _xtherapeutic use
700	1		_aDominguez, Adriana
700	1		_aDobrovolskaya, Natalia
700	1		_aGiotta, Francesco
700	1		_aTubiana-Mathieu, Nicole
700	1		_aPecherstorfer, Martin
700	1		_aArdizzoia, Antonio
700	1		_aBlasinska-Morawiec, Maria
700	1		_aEspinosa, Enrique
700	1		_aVillanova, Gustavo
773	0		_tClinical breast cancer _gvol. 18 _gno. 1 _gp. e41-e47
856	4	0	_uhttps://doi.org/10.1016/j.clbc.2017.05.012 _zAvailable from publisher's website
999			_c27328239 _d27328239